Print information to inform decisions about mammography screening participation in 16 countries with population-based programs

Patient Education and Counseling

Volumn 63, Issue 1-2, 2006, Pages 126-137

  Zapka, Jane G ^a   Geller, Berta M ^b   Bulliard, Jean Luc ^c   Fracheboud, Jacques ^d   Sancho Garnier, Helene ^e   Ballard Barbash, Rachel ^f  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e Epidaure CRLC   (France)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Decision making; Health communication; Mammography

Indexed keywords

ARTICLE; BREAST CANCER; HEALTH PROGRAM; HUMAN; MAMMOGRAPHY; MEDICAL DECISION MAKING; MEDICAL INFORMATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING;

AUSTRALIA; BREAST NEOPLASMS; CANADA; COMMUNITY HEALTH PLANNING; DECISION MAKING; DECISION SUPPORT TECHNIQUES; EUROPE; HEALTH CARE SURVEYS; HUMANS; INFORMED CONSENT; ISRAEL; JAPAN; MAMMOGRAPHY; MASS SCREENING; NEW ZEALAND; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; PROGRAM EVALUATION; RISK ASSESSMENT; RISK FACTORS; TEACHING MATERIALS;

EID: 33748295788     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2005.09.012     Document Type: Article

References (50)

1. Shapiro S., Benet W., Strax P., and Venet L. Periodic screening for breast cancer: the health insurance plan project and its sequelae (1988), The Johns Hopkins University Press, Baltimore, MD p. 55
2. Miller A.B., To T., Baines C.J., and Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 137 (2002) 305-312
3. Alexander F.E., Anderson T.J., Brown H.K., Forrest A.P., Hepburn W., Kirkpatrick A.E., Muir B.B., Prescott R.J., and Smith A. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 353 (1999) 1903-1908
4. Nystrom L., Andersson I., Bjurstam N., Frisell J., and Nordenskjold L.E. Long-term effects of mammography screening: updated Swedish randomised trials. Lancet 359 (2002) 909-919
5. Duffy S.W., Tabar L., Chen H.H., Holmqvist M., Yen M.F., Abdsalah S., Epstein B., Frodis E., Ljungberg E., Hedborg-Melander C., Sundbom A., Tholin M., Wiege M., Akerlund A., Wu H.M., Tung T.S., Chiu Y.H., Chiu C.P., Huang C.C., Smith R.A., Rosen M., Stenbeck M., and Holmberg L. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95 (2002) 458-469
6. Shapiro S., Coleman E.A., Broeders M., Codd M., de Koning H., Fracheboud J., Moss S., Paci E., Stachenko S., and Ballard-Barbash R. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol 27 (1998) 735-742
7. Hendrick R.E., Klabunde C., Grivegnee A., Pou G., and Ballard-Barbash R. Technical quality control practices in mammography screening programs in 22 countries. Int J Qual Health C 14 (2002) 219-226
8. Olsen O., and Gotzsche P.C. Cochrane review on screening for breast cancer with mammography. Lancet 358 (2001) 1340-1342
9. Freedman D.A., Petitti D.B., and Robins J.M. On the efficacy of screening for breast cancer. Int J Epidemiol 33 (2004) 43-55
10. Green B.B., and Taplin S.H. Breast cancer screening controversies. J Am Board Fam Pract 16 (2003) 233-241
11. Allweis T.M., Nissan A., Spira R.M., Sklair-Levy M., Freund H.R., and Peretz T. Screening mammography for early diagnosis of breast cancer: facts, controversies, and the implementation in Israel. Harefuah 142 (2003) 281-286 317
12. Briss P., Rimer B., Reilley B., Coates R.C., Lee N.C., Mullen P., Corso P., Hutchinson A.B., Hiatt R., Kerner J., George P., White C., Gandhi N., Saraiya M., Breslow R., Isham G., Teutsch S.M., Hinman A.R., and Lawrence R. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 26 (2004) 67-80
13. Sheridan S.L., Harris R.P., Woolf S.H., and The Shared Decision-Making Workgroup of the U.S. Preventive Services Task Force. Shared decision making about screening and chemoprevention. Am J Prev Med 26 (2004) 56-66
14. Burton A. Europe continues breast screening despite doubts. Lancet Oncol 3 (2002) 258
15. Edwards A, Unigwe S, Elwyn G, Hood K. Personalised risk communication for informed decision making about entering screening programs (Cochrane Review). Cochrane Database Syst Rev 2003:CD001865.
16. Rimer B.K., Briss P.A., Zeller P.K., Chan E.C., and Woolf S.H. Informed decision making: what is its role in cancer screening?. Cancer 101 (2004) 1214-1228
17. Jorgensen K.J., and Gotzsche P.C. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. Brit Med J 328 (2004) 148
18. Klabunde C., Bouchard F., Taplin S., Scharpantgen A., and Ballard-Barbash R. Quality assurance for screening mammography: an international comparison. J Epidemiol Commun H 55 (2001) 204-212
19. Klabunde C.N., Sancho-Garnier H., Broeders M., Thoresen S., Rodrigues V.J., and Ballard-Barbash R. Quality assurance for screening mammography data collection systems in 22 countries. Int J Technol Assess 17 (2001) 528-541
20. Ballard-Barbash R., Klabunde C., Paci E., Broeders M., Coleman E.A., Fracheboud J., Bouchard F., Rennert G., and Shapiro S. Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment. Eur J Cancer Prev 8 (1999) 417-426
21. Geller BM, Zapka JG, Hofvind S, Scharpantgen A, Giordano L, Ohuchi N, Ballard-Barbash R. Communicating with women about mammography, in press.
22. Miles A., Cockburn J., Smith R.A., and Wardle J. A perspective from countries using organized screening programs. Cancer 101 (2004) 1201-1213
23. Dobias K.S., Moyer C.A., McAchran S.E., Katz S.J., and Sonnad S.S. Mammography messages in popular media: implications for patient expectations and shared clinical decision-making. Health Expect 4 (2001) 131-139
24. Millett C., and Parker M. Informed decision making for cancer screening-not all of the ethical issues have been considered. Cytopathology 14 (2003) 3-4
25. Ward J. Population-based mammographic screening: does 'informed choice' require any less than full disclosure to individuals of benefits, harms, limitations and consequences?. Aust NZ J Publ Heal 23 (1999) 301-304
26. Wolf A.M., and Becker D.M. Cancer screening and informed patient discussions. Truth and consequences. Arch Intern Med 156 (1996) 1069-1072
27. Gordon-Lubitz R.J. MSJAMA. Risk communication: problems of presentation and understanding. J Am Med 289 (2003) 295
28. Slaytor E.K., and Ward J.E. How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets. Brit Med J 317 (1998) 263-264
29. Walter L.C., and Covinsky K.E. Cancer screening in elderly patients: a framework for individualized decision making. J Am Med 285 (2001) 2750-2756
30. Muhlhauser I., and Holdke B. Information on mammography screening-from deception to insight. Radiologe 42 (2002) 299-304
31. O'Connor A.M., Stacey D., Entwistle V., Llewellyn-Thomas H., Rovner D., Holmes-Rovner M., Tait V., Tetroe J., Fiset V., Barry M., and Jones J. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2003) CD001431
32. Rudd R.E., Kaphingst K., Colton T., Gregoire J., and Hyde J. Rewriting public health information in plain language. J Health Commun 9 (2004) 195-206
33. Raffle A.E. Information about screening-is it to achieve high uptake or to ensure informed choice?. Health Expect 4 (2001) 92-98
34. International Breast Cancer Screening Network. National Cancer Institute; 2004. Accessed at: http://appliedresearch.cancer.gov/ibsn/ on October 8, 2004.
35. Woloshin S., Schwartz L.M., and Welch H.G. Risk charts: putting cancer in context. J Natl Cancer I 94 (2002) 799-804
36. Edwards A., Elwyn G., and Mulley A. Explaining risks: turning numerical data into meaningful pictures. Brit Med J 324 (2002) 827-830
37. Schwartz L.M., Woloshin S., Black W.C., and Welch H.G. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 127 (1997) 966-972
38. Gigerenzer G., and Edwards A. Simple tools for understanding risks: from innumeracy to insight. Brit Med J 327 (2003) 741-744
39. Entwistle V. The potential contribution of decision aids to screening programmes. Health Expect 4 (2001) 109-115
40. Sieber W.J., and Kaplan R.M. Informed adherence: the need for shared medical decision making. Control Clin Trials 21 (2000) 233S-240S
41. Charles C., Gafni A., and Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 49 (1999) 651-661
42. Lewis M.L., Corcoran-Perry S.A., Narayan S.M., and Lally R.M. Women's approaches to decision making about mammography. Cancer Nurs 22 (1999) 380-388
43. Epstein R.M., Alper B.S., and Quill T.E. Communicating evidence for participatory decision making. J Am Med 291 (2004) 2359-2366
44. Entwistle V.A., Sowden A.J., and Watt I.S. Evaluating interventions to promote patient involvement in decision-making: by what criteria should effectiveness be judged?. J Health Serv Res Policy 3 (1998) 100-107
45. NCQA. HEDIS 3.0 Narrative: What's in it and why it matters. Washington, DC: National Committee for Quality Assurance; 1997.
46. Scanlon D.P., Darby C., Rolph E., and Doty H.E. The role of performance measures for improving quality in managed care organizations. Health Serv Res 36 (2001) 619-641
47. European Guidelines for Quality Assurance in Mammography Screening. 3rd ed. Europe Against Cancer, Office for Official Publications of the European Communities; January 2001.
48. Hussey P.S., Anderson G.F., Osborn R., Feek C., McLaughlin V., Millar J., and Epstein A. How does the quality of care compare in five countries?. Health Affair 23 (2004) 89-99
49. Domenighetti G., D'Avanzo B., Egger M., Berrino F., Perneger T., Mosconi P., and Zwahlen M. Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol 32 (2003) 816-821
50. Bulliard J.L., and Levi F. Women's perception of mammography screening. Int J Epidemiol 33 (2004) 903-904